Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
67.06(c) 67(c) 67.24(c) 68.64(c) 68.7 Last
1 492 261 670 858 748 396 807 171 624 837 Volume
-5.52% -0.09% +0.36% +2.08% +0.09% Change
More quotes
Financials (USD)
Sales 2020 21 505 M - -
Net income 2020 1 548 M - -
Net Debt 2020 14 305 M - -
P/E ratio 2020 15,4x
Yield 2020 1,74%
Sales 2021 22 512 M - -
Net income 2021 1 696 M - -
Net Debt 2021 13 444 M - -
P/E ratio 2021 14,1x
Yield 2021 1,84%
Capitalization 23 836 M 23 792 M -
EV / Sales 2020 1,77x
EV / Sales 2021 1,66x
Nbr of Employees 124 736
Free-Float 65,1%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions; - manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by... 
More about the company
Notations Surperformance© of Fresenius Medical Care AG & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
05:24aFMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Buy rating
MD
04:44aFRESENIUS SE : Buy rating from JP Morgan
MD
04:25aFMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Goldman Sachs
MD
03:00aFMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg gives a Buy rating
MD
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
MD
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
MD
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
MD
10/21Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
AQ
10/21FRESENIUS SE : Barclays reiterates its Buy rating
MD
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Barclays
MD
10/20FRESENIUS MEDICAL CARE : gets FDA approval for Biofineģ PD solution bags
PU
10/20FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan reaffirms its Buy rating
MD
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
05:24aFMC FRESENIUS MEDICAL CARE AG & CO K : Opinion positive de JP Morgan
05:24aJPMorgan belässt FMC auf 'Overweight' - Ziel 94,80 Euro
04:44aJPMorgan belässt Fresenius SE auf 'Overweight' - Ziel 60,40 Euro
04:25aFMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs réitère son opinion positiv..
04:25aGoldman belässt FMC auf 'Conviction Buy List' - Ziel 87,50 Euro
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 99,78 $
Last Close Price 81,40 $
Spread / Highest target 41,0%
Spread / Average Target 22,6%
Spread / Lowest Target -1,84%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer